INDEX VENTURES LIFE VI (JERSEY) L.P.

CIK 1591199 · last filed 2026-06-24

INDEX VENTURES LIFE VI (JERSEY) L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for CNTA, was dated Jun 24, 2026. Across all open-market trades the lifetime net is +$4.4M, making them a net buyer over the disclosed history. The firm reports its address in St. Helier, Y9. 6 SEC filings were submitted jointly with (Jersey) SLP Yucca.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
2
Lifetime Open-Market Net
$4.45M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

EGLT price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
OGIER HOUSE
THE ESPLANADE
ST. HELIER, Y9 JE4 9WG
Phone
44-1534-504000
State of Incorporation
Jersey
Related Filers
(Jersey) SLP Yucca — 6 joint filings, latest 2026-06-24
Index Venture Associates III Ltd — 3 joint filings, latest 2014-02-13
Index Ventures III (Delaware) L.P. — 3 joint filings, latest 2014-02-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Centessa Pharmaceuticals plc (CNTA) Delisted 10%+ Owner 0 $40.50 $0 $0 1 2026-06-24
Zyla Life Sciences (EGLT) Delisted 10%+ Owner 207,147 — — $4.45M 1 2014-02-13

Holdings By Holder

Who holds the shares on record: the insider directly, and each trust, LLC, partnership or family member reported as an indirect holder on the latest Form 4 that lists them. Holder names come from the filing's footnotes. Rows under No longer reported appeared on earlier filings but not the latest one, usually because the holder was emptied or folded into another; they are not counted in the total.
Symbol Holder Shares Share of Total Reported
CNTA Index Ventures Life VI
See footnote
0 — 2026-06-24
Total 0
EGLT Direct 25,891 12.5% 2014-02-13
By Egalet A/S 181,256 87.5% 2014-02-13
Total 207,147

Recent Filings

2 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2026-06-24 Centessa Pharmaceuticals plc (CNTA) Delisted Sell (S) −9,961,789 $0 EDGAR
2014-02-13 Zyla Life Sciences (EGLT) Delisted Buy (P) +370,833 $4.45M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).